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Abstract 17 
 18 
Experimental 13C solid-state magic-angle spinning (MAS) NMR as well as DFT (gauge-19 
including projector augmented wave) GIPAW calculations were used to probe disorder and 20 
local mobility in diethylcarbamazine citrate, (DEC)+(citrate). This compound has been used 21 
as the first option drug for the treatment of filariasis, a disease endemic in tropical countries 22 
and caused by adult worms of Wuchereria bancrofti, which is transmitted by mosquitoes. We 23 
firstly present 2D 13C-1H dipolar-coupling mediated heteronuclear correlation spectra 24 
recorded at moderate spinning frequency, to explore the intermolecular interaction between 25 
DEC and citrate molecules. Secondly, we investigate the dynamic behaviour of 26 
(DEC)+(citrate)by varying the temperature and correlating the experimental MAS NMR 27 
results with DFT GIPAW calculations that consider two (DEC)+ conformers (in a 70:30 ratio) 28 
for crystal structures determined at 293 and 235 K. Solid-state NMR provides insights on 29 
slow exchange dynamics revealing conformational changes involving particularly the 30 
diethylcarbamazine ethyl groups.  31 
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Introduction 1 
 2 
Molecular mobility in organic and inorganic solids is important because it can predict 3 
changes in the crystal structure [1-5]. In the solid state, intra- and intermolecular interactions 4 
have an important effect on the observed molecular mobility and consequently the stability of 5 
the crystal structure [6]. In some cases, these local dynamics are responsible for phase 6 
transitions between two or more metastable forms and (un)desired polymorphs can be 7 
obtained [2, 4, 7-11]. Therefore, the characterization of these processes is important and can be 8 
achieved by X-ray diffraction (XRD) methods as well as solid-state NMR [12-17]. For organic 9 
compounds, such as active pharmaceutical ingredients, XRD methods can be used to describe 10 
some molecular disorder with good precision, but a description of local dynamics remains 11 
challenging [18]. For these cases, solid-state NMR is an invaluable technique, due to its high 12 
sensitivity to small changes in the orientation of specific chemical moieties, as revealed, for 13 
example, by changes in their chemical shifts [19].  14 
This paper applies solid-state NMR to probe disorder and local mobility in 15 
diethylcarbamazine dihydrogen citrate, referred to here as diethylcarbamazine citrate, 16 
(DEC)+(citrate) or simply DEC-cit. This compound has been used as the first option drug for 17 
the treatment of filariasis, a disease endemic in tropical countries and caused by adult worms 18 
of Wuchereria bancrofti, which is transmitted by mosquitoes [20, 21]. Due to its good thermal 19 
stability, DEC-cit can be added to the table salt used by patients, to guarantee a good 20 
adherence to the treatment [20, 22, 23]. Silva and co-workers [24] described the existence of three 21 
different phase transitions, leading to four different crystal packings at 293, 235, 150 and 100 22 
K. Additionally, they also reported the existence of two possible conformers (in a 70:30 ratio) 23 
for the 293 and 235 K crystal structures due to the existence of a disorder in one of the two 24 
ethyl branches of the diethylcarbamazine unit. In a separate paper, we have presented 1H fast 25 
magic-angle spinning (MAS) NMR spectra for DEC-cit as well as a GIPAW (gauge-26 
including projector augmented wave) calculation of NMR parameters for the 70% conformer 27 
of the 293 K structure [25]. In this paper, we examine the temperature dependence of the 13C 28 
chemical shifts and present GIPAW calculations for all the distinct crystal structures and 29 
conformers reported by Silva et al. In particular, we observe dynamics for the dihydrogen 30 
citrate molecule, for which there is little discussion of disorder in Ref. [24]. 31 
The use of solid-state NMR for studying dynamic processes in solid samples is not new, but 32 
the challenge resides in the complexity of the molecular packing in crystalline structures such 33 
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as biomolecules, as well as for flexible domains in small molecules [19, 26]. Among several 1 
NMR parameters used to study dynamics are changes in the chemical shifts and linewidth, as 2 
well as also changes in relaxation times and the magnitude of anisotropic interactions (dipolar 3 
coupling, chemical shift anisotropy, quadrupolar interaction) [18, 19, 26-29]. In this context, the 4 
use of an NMR crystallography approach that combines experimental high resolution solid-5 
state NMR with GIPAW calculations is a promising strategy [19, 30]. This combination permits 6 
an investigation of which atoms are involved in the dynamics, since their chemical shifts 7 
change according to their new orientations. Hence, our strategy was to use the DEC-cit 8 
crystal structures previously determined by XRD at different temperatures and use the NMR 9 
crystallography approach to evaluate the dynamics of DEC-cit based on the chemical shift 10 
variations. For this purpose, we used DFT GIPAW calculations to obtain the chemical shifts 11 
of six different structures at room and low temperatures together with 13C experimental solid-12 
state NMR for evaluating the dynamics over the temperature range from –40 and +50 oC. 13 
Specifically, we firstly describe the use of 2D 13C-1H heteronuclear correlation modulated by 14 
dipolar couplings at moderate spinning frequency, to explore the intermolecular interaction 15 
between DEC and citrate molecules. Secondly, we describe the dynamic behaviour of DEC-16 
cit by varying the temperature and correlating the experimental MAS NMR results with DFT 17 
GIPAW calculations. We were able to explore the disorder of the ethyl moieties in DEC as 18 
well as the phase transition between two phases of DEC-cit, focusing on the citrate molecule. 19 
 20 
Experimental and computational details 21 
 22 
Experimental 23 
Sample and packing: the active pharmaceutical ingredient, diethylcarbamazine citrate, was 24 
kindly donated by Fundação Oswaldo Cruz – Farmanguinhos, Rio de Janeiro, and used as 25 
received. Approximately 60 mg of the powdered sample were packed into a 4 mm zirconia 26 
MAS NMR rotor. 27 
13C detected MAS NMR experiments: 1H-13C cross polarization (CP) MAS experiments were 28 
performed using a Bruker Avance III spectrometer operating with a narrow bore 11.7 T 29 
magnet (500 MHz for 1H resonance frequency) and equipped with a HXY probehead for 4 30 
mm rotors. A MAS frequency of 5 kHz was used. A two pulse phase modulated TPPM-15 31 
scheme [31, 32] was used for 1H decoupling at a nutation frequency of 83.3 kHz. CP was 32 
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applied by using a 90-100% amplitude ramp on 1H [33] during a contact time of 2 ms. 256 1 
transients were coadded with a recycle delay of 3 s. Adamantane was used as an external 2 
reference for tetramethylsilane (TMS), setting the CH2 signal to 38.5 ppm 
[34, 35].  3 
2D CP - 1H (FSLG)-13C Heteronuclear Correlation [36]: two different experiments (by 4 
varying contact time) were performed using a Bruker Avance III spectrometer operating with 5 
a wide bore 11.7 T magnet (500 MHz for 1H resonance frequency) and using a 4 mm HXY 6 
probehead at a MAS frequencies of 12.5 kHz (for short contact time experiment) and 10.0 7 
kHz (for long contact time experiment), at 22 oC. Both homonuclear (FSLG, [37, 38]) and 8 
heteronuclear SPINAL-64 [39] 1H decoupling employed a nutation frequency of 100 kHz. For 9 
each of 128 t1 FIDs (using the States method to achieve sign discrimination in F1 with a rotor 10 
asynchronized increment of 36 μs for LG period). For short contact time experiment 16 11 
transients were coadded with a recycle delay of 11 s, corresponding to a total experimental 12 
time of 6.5 h. For long contact time experiment 64 transients were coadded with a recycle 13 
delay of 2.5 s, corresponding to a total experimental time of 3 h. For CP (contact time of 50 14 
and 2000 s), a 90-100% amplitude ramp on 1H was employed [33]. The scaling factor in F1 15 
was 0.56 (50 s) and 0.55 (2000 s). 13C chemical shifts were referenced using L-alanine as 16 
an external reference (using the CH3 signal at 20.5 ppm), corresponding to the same 17 
adamantane reference referred to above. 18 
 19 
DFT GIPAW Calculations:  20 
 21 
Calculations were performed by employing a plane-wave based DFT approach as 22 
implemented in the CASTEP code, UK academic release version 8.0 [40]. Initial atomic 23 
coordinates were taken from the published crystal structures [24] for which the “.cif” files are 24 
available on the Crystallography Open Database 25 
http://www.crystallography.net/cod/cod/4501669.html, with codes: 4501669 (293 K), 26 
4501670 (235 K), 4501671 (150 K), 4501672 (100 K). All crystallographic parameters, such 27 
as cell dimensions and angles among others, are described in Ref [24]. The crystal structures 28 
obtained at 235 and 100 K both contain two ionic pairs per unit cell whilst those obtained at 29 
150 and 293 K contain one. For the 235 and 293 K crystal structures, two different 30 
conformers are described, due to the disorder related to one of the ethyl groups. In these 31 
cases, two “.cif” files were created: for the first conformer the C7A', C8A', H8A1', H8A2', 32 
H8A3', H7A1' and H7A2' atoms were manually deleted; and for the second one these atoms 33 
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were preserved and the C7A, C8A, H8A1, H8A2, H8A3, H7A1 and H7A2 were instead 1 
manually deleted. Hence, a total of six “.cif” files were used for GIPAW calculations. (Note 2 
that calculated NMR parameters for the 293 K first conformer have been presented in Ref. 3 
[25].) 4 
The unit cell parameters were fixed, space group symmetry was imposed, and periodic 5 
boundary conditions were applied during the geometry optimization. NMR shielding 6 
calculations were performed using the gauge-including projector-augmented wave (GIPAW) 7 
approach [41, 42]. Both geometry optimizations and NMR chemical shift calculations used a 8 
plane-wave basis set and the PBE exchange correlation functional [42, 43] at a basis cut-off 9 
energy of 700 eV, with integrals taken over the Brillouin zone by using a Monkhorst−Pack 10 
grid of minimum sample spacing 0.1  2 Å1. A semi empirical dispersion correction was 11 
applied using the TS scheme [44] during both geometry optimization and NMR shielding 12 
calculations, employing ultrasoft pseudopotentials generated on the fly (OTF) [45]. After 13 
geometry optimization, the forces, energies and displacements were better than 0.05 eV  Å−1, 14 
0.000002 eV and 0.0002 Å, respectively. Distances stated in this paper are for the geometry-15 
optimised structures. GIPAW calculated NMR shielding were visualized, processed, and 16 
tabulated through the CCP-NC output files visualization tool, MagresView version 1.6 [46], 17 
running on Mozilla Firefox web browser version 49.0.2.  18 
 19 
Results 20 
 21 
1H-13C Heteronuclear Correlation 2D MAS NMR spectroscopy 22 
 23 
Intermolecular interactions between (DEC)+ and (citrate) molecules are revealed by the 1H-24 
13C CP-FSLG-HETCOR experiment. Two spectra were recorded with two different CP 25 
contact times: 50 (Fig. 1a) and 2000 s (Fig. 1b). The experiment using 50 s (Fig. 1a) 26 
exhibits mainly those cross peaks related to directly bonded carbon and hydrogen atoms. In 27 
Fig. 1b, the use of a longer CP contact time (2000 s) leads to the observation of three 28 
correlations (shown by shaded circles) between the NH+ (H22) proton with carbons C8, C42 29 
and C44. As shown on the right-hand side of Fig. 1, these correspond to close intramolecular 30 
(C8) and intermolecular (C42, C44) distances. Note that no correlation peaks with C9 and C7 31 
are observed, with this likely being due to different spin dynamics for these CH2 groups.  32 
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 1 
 2 
Figure 1: 1H (500 MHz)-13C HETCOR MAS NMR spectra of diethylcarbamazine citrate 3 
recorded using FSLG 1H decoupling and CP contact times of (a) 50 (12.5 kHz) and (b) 2000 4 
s (10.0 kHz). The base contour is at (a) 20% and (b) 7% of the maximum height. The 5 
projections on the right-hand side of the two 2D spectra are 1H-13C CP MAS spectra recorded 6 
at the same magnetic field strength (11.4 T) using a 2 ms contact time. On the right hand side, 7 
a view of the geometry optimized (CASTEP) structure is shown; the proximities of H22 8 
(NH+) to C8, C42 and C44 corresponding to observed cross peaks (red highlighting in b) are 9 
indicated.   10 
 11 
Variable-temperature 1H-13C CP MAS NMR spectroscopy 12 
 13 
Figs. 2 and 3 present 1H-13C CP MAS spectra of the DEC-cit sample for two different 14 
temperatures ranges: below and above 0 oC, respectively. Consider first the spectra in Fig. 2 15 
recorded at low temperatures: the chemical shifts for specific carbon atoms are observed to 16 
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increase upon increasing the temperature from 40 oC to 0 oC. The biggest changes are 1 
observed for carbons C1, C4 and C42.  2 
 3 
Figure 2: 1H (500 MHz)-13C CP MAS (5 kHz) spectra for diethylcarbamazine citrate at 4 
different temperatures from 0 to 40 oC. Expanded regions are shown to improve the 5 
visualization.  6 
 7 
Regarding the dynamics of the (citrate)– molecule, we can see evident changes for carbons 8 
C42 and C46. The chemical shift of C42 varies from 72.5 (40 oC) to 73.0 ppm (+50 oC). It is 9 
also observed that the lineshape for carbon C46 changes for the lower temperature range 10 
(below 25 oC), with a shoulder appearing (on the lower-ppm side) as highlighted by the 11 
arrows in Fig. 2. A closer look at this resonance is presented in Fig. 4. Specifically, it is 12 
possible to observe that the principal signal shifts to a higher ppm value as the temperature 13 
decreases, from 173.3 to 173.4 ppm, while below 25 oC a slight shoulder starts to appear at 14 
173.2 ppm (see the red shaded area in Fig. 2).  15 
 16 
Consider now changes for the (DEC)+ unit. Further to changes for C1 and C4 (assigned to the 17 
terminal CH3 groups of the ethyl moieties) observed at low temperature (Fig. 2), the most 18 
interesting changes take place at higher temperatures (above 20 oC, see Fig. 3). Specifically, a 19 
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broadening of the C1 and C4 resonances is observed, followed by coalescence at 35 oC, 1 
before the resonances start to narrow at around 14 ppm at 40 oC and higher temperatures. 2 
This corresponds to the well-known exchange phenomenon on moving from slow exchange 3 
to intermediate exchange to fast exchange. [47-50]. Marked temperature-dependent changes are 4 
also observed for the peaks between 40 and 45 ppm, notably at 42.5 and 44.5 ppm with 5 
considerable broadening at some temperatures. This is a crowded region of the spectrum 6 
corresponding to C2, C3, C8, C10 and C45, with the obvious explanation being that the 7 
changes are for C2 and C3.  Only small changes (see C7 and C9 in Fig. 3) are observed for 8 
the carbons from the piperazine 6-member ring, showing that the chair conformation of this 9 
ring is preserved.  10 
 11 
 12 
Figure 3: 1H (500 MHz)-13C CP MAS (5 kHz) spectra for diethylcarbamazine citrate at 13 
different temperatures from 0 to 50 oC. Expanded regions are shown to improve the 14 
visualization. 15 
 16 
 17 
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 1 
Figure 4: 1H (500 MHz)-13C CP MAS (5 kHz) spectra for diethylcarbamazine citrate at 2 
different temperatures from 0 to 40 oC. Expanded regions are shown so as to better visualize 3 
changes for the C46 resonance. 4 
 5 
Using GIPAW calculations to interpret the experimental MAS NMR observations 6 
 7 
When Silva et al [24] described the room-temperature crystal structure of DEC citrate salt, 8 
they also reported the existence of three phase transitions between four different phases at 9 
293, 235, 150 and 100 K, mostly involving changes for the two ethyl moieties (i.e, C1, C2, 10 
C3, C4). For the 235 and 293 K structures, they also describe the existence of two possible 11 
conformers, related to the observed disorder. Table 1 lists the GIPAW calculated chemical 12 
shifts for these distinct crystal structures and conformers (after initial geometry optimisation). 13 
The Table also lists the maximum range for each chemical site, with the biggest changes (> 3 14 
ppm) for 13C observed for C1 to C6 and C45.  15 
 16 
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Table 1: Experimentala (293K) and GIPAWb calculated isotropic NMR chemical shifts (in ppm) for different phases of the diethycarbamazine 1 
citrate salt at different temperatures (100, 150, 235 and 293 K).  2 
Atom XRD labelling [24] Atom 
descriptor 
phase 100K phase 150 K phase 235 K phase 293 K iso 
calc 
(max 
over all 
phases) 
Experimental 
293 K conformer 1 conformer 2 conformer 1 conformer 2 
molecule 1 molecule 2 
 
molecule 1 molecule 2 molecule 1 molecule 2 Ref [25] 
 
Ref [25] 
iso
calc iso
calc iso
calc iso
calc iso
calc iso
calc iso
calc iso
calc iso
calc iso
exp 
C1 C10A CH3 14.1 10.5 10.4 10.6 10.4 13.2 10.5 10.9 13.7 3.7 14.2 
C2 C9A CH2 45.3 41.0 41.0 42.1 41.1 50.9 41.2 42.0 44.3 9.9 42.1 
C3 C7A CH2 47.8 41.2 41.2 40.0 41.1 44.9 41.2 40.5 50.6 10.6 40.7 
C4 C8A CH3 9.9 8.6 8.7 8.6 8.7 14.2 8.8 8.6 13.0 5.6 13.6 
C5 C6A C=O 161.4 162.6 158.5 163.3 158.8 160.6 158.7 163.0 160.1 4.6 164.9 
C6 C4A CH2 47.0 48.7 46.5 49.0 46.8 49.6 46.7 49.3 46.5 3.1 48.2 
C7 C3A CH2 51.3 50.4 51.5 50.8 51.7 50.3 51.5 50.9 50.6 1.4 51.3 
C8 C5A CH3 44.7 44.7 44.4 44.0 44.3 44.9 44.3 44.2 44.5 0.9 44.8 
C9 C2A CH2 53.0 52.7 53.3 53.3 53.4 53.0 53.2 53.0 52.9 0.7 53.2 
C10 C1A CH2 40.9 43.9 42.2 43.1 42.6 42.3 41.6 43.4 41.9 3.0 44.5 
C41 C6C COOH 181.4 181.8 180.8 181.0 180.9 180.7 181.0 180.9 180.7 1.1 177.6 
C42 C3C Cq 74.2 74.3 74.0 74.5 73.8 74.0 73.7 74.2 73.7 0.8 72.8 
C43 C2C CH2 49.7 49.9 49.2 49.6 49.0 49.0 49.3 49.1 48.7 1.2 46.8 
C44 C1C COO- 179.9 179.7 179.3 179.3 179.6 179.0 179.4 179.3 179.0 0.9 177.3 
C45 C4C CH2 53.6 41.7 42.9 42.5 53.8 42.3 42.6 42.6 41.7 12.1 42.4 
C46 C5C COOH 176.7 176.6 176.6 176.1 176.9 176.3 176.9 176.3 176.1 0.8 173.3 
 
H1,H2,H3 H10A1,H10A2,H10A3 CH3 0.2 0.4 0.1 0.4 0.2 0.5 0.2 0.4 0.4 0.4 0.5 
H4 H9A1 CH2 2.8 2.5 2.4 2.6 2.5 2.3 2.5 2.5 2.2 0.6 2.5 
H5 H9A2 CH2 2.4 2.5 2.4 2.4 2.5 2.8 2.5 2.3 2.7 0.5 2.5 
H6 H7A1 CH2 2.9 2.6 2.7 2.6 2.9 2.8 2.9 2.1 1.9 1.0 2.3 
12 
 
H7 H7A2 CH2 2.1 2.1 2.2 2.2 2.3 2.0 2.3 2.5 2.8 0.8 2.3 
H8, H9,H10 H8A1, H8A2, H8A3 CH3 0.3 0.2 0.2 0.2 0.3 0.0 0.3 0.1 -0.1 0.4 0.5 
H11 H4A1 CH2 2.7 2.7 2.8 2.8 3.0 2.8 3.0 2.7 2.7 0.3 2.7 
H12 H4A2 CH2 2.8 2.8 3.0 2.9 3.1 2.9 3.1 2.8 2.8 0.3 2.7 
H13 H3A1 CH2 2.7 3.1 2.6 3.1 2.6 3.2 2.6 2.9 3.0 0.5 2.8 
H14 H3A2 CH2 3.1 3.2 3.0 3.2 3.1 3.4 3.1 3.3 3.4 0.4 2.8 
H15,H16,H17 H5A1, H5A2, H5A3 CH3 2.2 2.1 2.2 2.3 2.3 2.3 2.3 2.1 3.1 1.0 2.3 
H18 H2A1 CH2 2.4 2.4 2.4 2.4 2.6 2.4 2.6 2.4 2.3 0.3 2.7 
H19 H2A2 CH2 3.1 3.0 3.0 3.1 3.0 3.1 3.0 3.0 3.0 0.1 2.7 
H20 H1A1 CH2 3.7 3.6 3.8 3.7 3.9 3.7 3.9 3.6 3.7 0.3 2.9 
H21 H1A2 CH2 2.7 2.5 2.6 2.9 2.6 2.9 2.7 2.7 2.8 0.4 2.9 
H22 H2A N+H 9.2 9.2 8.7 9.7 8.7 9.4 8.7 9.4 9.2 1.0 9.1 
H89 H2C1 CH2 1.5 1.7 1.4 1.7 1.5 1.7 1.5 1.6 1.6 0.3 2.5 
H90 H2C1 CH2 2.3 2.3 2.1 2.4 2.2 2.3 2.3 2.3 2.3 0.3 2.5 
H91 H4C1 CH2 2.6 2.5 2.4 2.5 2.6 2.5 2.6 2.5 2.4 0.2 2.7 
H92 H4C2 CH2 2.1 2.2 2.1 2.3 2.2 2.3 2.2 2.1 2.1 0.2 2.7 
H93 H6C COOH 17.1 17.1 17.4 16.9 17.5 16.9 17.3 16.7 16.9 0.8 16.2 
H94 H3C OH 4.4 4.5 4.2 4.4 4.2 3.8 4.3 4.2 3.6 0.9 4.8 
H95 H7C COOH 14.1 14.0 13.9 14.1 14.2 14.1 14.2 14.3 14.2 0.4 12.8 
 
N1 N2A N(C=O)N -284.1 -282.1 -275.6 -285.7 -275.0 -274.3 -274.9 -286.8 -274.9 12.5 -287.7 
N2 N1A N(C=O)N -296.4 -300.0 -304.6 -299.2 -305.1 -308.6 -305.2 -309.4 -309.1 13.0 -308.4 
N3 N3A N+H -331.0 -330.6 -331.0 -331.3 -330.4 -331.8 -330.6 -328.6 -331.4 3.2 -336.4 
a It is not possible to distinguish and separate CH2 and CH3 1H resonances in the experimental spectra.  1 
13 
 
b Calculated isotropic chemical shifts are given by isocalc  =  ref – calc, where ref was 30 ppm for 1H and 153 ppm for 14N/15N. For 13C, two shielding references were 1 
determined: ref = 170 ppm for iso ≥ 70 ppm and ref = 173 ppm for iso ≤ 70 ppm [51]. For CH3 groups, the stated calculated isotropic chemical shift corresponds to the 2 
average for the three protons. 3 
 4 
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 1 
Figure 5: Geometry optimized structures of both conformers (from the X-ray diffraction 2 
structure) of diethylcarbamazine at 293 K (conformer 2 is shown in green): (a) the full 3 
(DEC)+ molecule, (b) a zoomed-in view for the carbon atoms that exhibit disorder, with the 4 
dihedral angles noted. 5 
 6 
It is clearly observed that the carbons C1 to C5 are involved in the disorder and their 7 
chemical shifts follows the changes in their orientation, as revealed by GIPAW calculations 8 
at 293 K. According to these calculations, C3 and C4 are mostly affected, and this finding 9 
reflects the differences in their chemical shifts ( is 10.1 and 4.4 ppm, respectively), as well 10 
as the dihedral angles (see Fig. 5). By comparison, for C1, C2 and C5,  is 2.8, 2.3 and 2.9 11 
ppm, respectively. Indeed, Silva et al [24] have already described a non-classical 12 
intermolecular hydrogen bond formed between the terminal CH3 (C1) group from the DEC 13 
unit with a carboxyl group from a citrate unit. They report that this interaction is responsible 14 
for keeping this methyl group ordered, in contrast to the second one (C4). Surprisingly small 15 
changes are observed in Table 1 for protons bonded to C1-C4. A  of 11.9 is observed for 16 
the calculated 15N chemical shift of nitrogen N1, also involved in the disorder.  17 
When we compare the calculated chemical shifts with the experimental ones, an interesting 18 
behaviour is observed. The experimental chemical shifts of C1 and C4 have a good 19 
agreement with the calculated ones for conformer 2. However, the experimental chemical 20 
shifts for C2, C3 and C5 exhibit a better agreement with those calculated for conformer 1. In 21 
the supporting information full spectra are shown in Fig. S1, and no signals can be observed 22 
below 10 ppm, except for spinning sideband peaks. To explore this interesting finding, we 23 
prepared “.cif” files for two new conformers, named conformer 3 and 4. For conformer 3, we 24 
15 
 
took the “.cif” file from conformer 1, replacing the atomic coordinates of C1 and C4 by those 1 
ones from conformer 2. The “.cif” file for conformer 4 was prepared from the atomic 2 
coordinates of conformer 2, replacing the positions of C1 and C4 by those from conformer 1. 3 
These new structures were optimized using DFT (in CASTEP), and the chemical shifts were 4 
calculated by using the GIPAW method  see Table 2. Additionally, the optimized (DEC)+ 5 
structures are shown in Fig. 6. 6 
 7 
Table 2. Experimental (293K) [25] and GIPAWa calculated isotropic NMR chemical shifts for 8 
13C nuclei for different conformers of the diethycarbamazine citrate salta at 293 K. 9 
Cb 
 
iso calc / ppm iso calc ppm iso calc / ppm iso calc / ppm iso exp 
  
conformer 1c conformer 2 c conformer 3d conformer 4e ppm 
C1 CH3 10.9 13.7 13.8 9.6 14.2 
C2 CH2 42.0 44.3 50.0 42.6 42.1 
C3 CH2 40.5 50.6 45.9 41.5 40.7 
C4 CH3 8.6 13.0 13.5 8.0 13.6 
C5 C=O 163.0 160.1 160.5 163.4 164.9 
C6 CH2 49.3 46.5 46.6 48.8 48.2 
C7 CH2 50.9 50.6 50.8 50.1 51.3 
C8 CH3 44.2 44.5 44.3 44.1 44.8 
C9 CH2 53.0 52.9 53.6 52.7 53.2 
C10 CH2 43.4 41.9 42.7 43.2 44.5 
C41 COOH 180.9 180.7 180.3 180.9 177.6 
C42 Cq 74.2 73.7 74.2 75.2 72.8 
C43 CH2 49.1 48.7 48.9 48.8 46.8 
C44 COO- 179.3 179.0 178.8 178.7 177.3 
C45 CH2 42.6 41.7 42.1 41.9 42.4 
C46 COOH 176.3 176.1 176.6 175.1 173.3 
a Calculated isotropic chemical shifts are given by isocalc  =  ref – calc, where two shielding references were 10 
determined: ref = 170 ppm for iso ≥ 70 ppm and ref = 173 ppm for iso ≤ 70 ppm [51], as presented in Table 1. 11 
b Italic denotes the carbons affected most by changing the positions of C1 and C4. 12 
c optimized from the original “.cif” file, conformer 1 values taken from Ref. [25]. 13 
d prepared from the “.cif” file of conformer 1, replacing the C1 and C4 atomic coordinates by those ones from 14 
conformer 2. 15 
e prepared from the “.cif” file of conformer 2, replacing the C1 and C4 atomic coordinates by those ones from 16 
conformer 1. 17 
16 
 
Upon a second comparison between the experimental MAS NMR data with the full set of 1 
calculated data in Table 2, we conclude that our experimental solid-state NMR data is most 2 
similar to the conformer 1, with the prevision that the C1 and C4 of the methyl groups are 3 
more affected by dynamics, as revealed by the variable temperature 13C CP MAS NMR 4 
spectra in Figs. 2 and 3.  5 
 6 
 7 
Figure 6: Geometry optimized structures of as-constructed (see discussion in the main text) 8 
conformers 3 and 4 of diethylcarbamazine at 293 K (conformer 4 is shown in green): (a) the 9 
full (DEC)+ molecule, (b) a zoomed-in view for the carbon atoms that exhibit disorder, with 10 
the dihedral angles noted. 11 
 12 
As shown in Figures 2 to 4, some slow dynamics is observed for the (citrate)– molecule. 13 
However, it is curious that no evident temperature-dependent experimental changes are 14 
observed for most of the 13C chemical shifts of (citrate)– molecule, except for C42 and C46 15 
(as discussed above). Table 1 shows that the GIPAW calculated 13C chemical shifts for C42 16 
are different for the two conformers at 293K (73.7 and 74.2 ppm) such that a change in 17 
relative population for the two distinct conformers could be an explanation for the 18 
experimental findings. 19 
For carbon C46, a shift from 176.3 ppm (at 293 K) to an average chemical shift of 176.9 ppm 20 
(235 K) is observed, if only the most probable conformer (conformer 1) is considered. 21 
However, the XRD analysis also predicts the existence of two molecules in the same unit cell 22 
for this conformer [24] and the GIPAW calculations indicate two values of 176.9 and 176.1 23 
17 
 
ppm for the C46 resonance. Similarly, two distinct values of 176.9 and 176.1 ppm are also 1 
calculated for the other conformer (conformer 2). Since the changes in both the calculated 2 
and experimental 13C chemical shifts are small, it is not possible to offer a clear explanation, 3 
but the appearance of the shoulder at 173.2 ppm at low temperature (see red shading in Fig. 4 
2) may be an indication of the start of the phase transition whereby two distinct resonances 5 
are observed due to the two distinct molecules in the asymmetric unit cell for the 235 K 6 
phase.  7 
 8 
Conclusions 9 
 10 
Variable temperature 13C solid state NMR spectra provide insight into the dynamics of both 11 
DEC and citrate molecules. The chair conformation of piperazine 6-member ring from DEC 12 
molecule does not change, with no significant chemical shift changes being observed. In 13 
contrast, ethyl moieties exhibit the biggest variation, in line with disorder in the XRD 14 
structures. Additionally, some dynamics was observed for the citrate unit, not described by 15 
XRD data. GIPAW calculations are particularly useful to explain changes observed in the 16 
experimental spectra, as well as to explore the possibility of having four different conformers 17 
for (DEC)+(citrate)salt indicating that there is a major conformer. The challenge for 18 
describing a precise crystal structure for this salt is the high mobility of methyl groups (C1 19 
and C4) of the DEC molecule, as observed by variable temperature 13C CP MAS NMR.  20 
In contrast to XRD methods, solid state NMR provided insights on the fast exchange 21 
dynamics showing the conformational changes involving particularly the ethyl moieties of 22 
diethylcarbamazine molecule. GIPAW calculations were especially useful to monitor the 23 
carbons involved in disorder, previously described, and allowed the possibility of having an 24 
average structure between two conformers at 293 K to be explored. Particularly for GIPAW 25 
calculations, it is still challenging to include the effect of temperature, but initial results are 26 
being presented [19, 30, 52, 53]. A recent approach uses the combination of molecular dynamics 27 
and path integer approach to treat the system in terms of quantum mechanics [54-56], but it is 28 
still computationally expensive and not fully available in routine jobs. 29 
 30 
  31 
 32 
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